Evaluation of the Autonomic Nervous System in a Canine Model of Chronic Embolic Pulmonary Hypertension

[1]  Scott A. Brown,et al.  ACVIM consensus statement: Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats , 2018, Journal of veterinary internal medicine.

[2]  Y. Miyagawa,et al.  Pharmacokinetics of single‐dose sildenafil administered orally in clinically healthy dogs: Effect of feeding and dose proportionality , 2018, Journal of veterinary pharmacology and therapeutics.

[3]  A. Rothman,et al.  Challenges in the development of chronic pulmonary hypertension models in large animals , 2017, Pulmonary circulation.

[4]  Simon Gibbs,et al.  2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. , 2016, Revista espanola de cardiologia.

[5]  Héctor Bueno,et al.  Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar , 2016 .

[6]  E. Skrzydlewska,et al.  Sildenafil reduces signs of oxidative stress in pulmonary arterial hypertension: Evaluation by fatty acid composition, level of hydroxynonenal and heart rate variability , 2015, Redox biology.

[7]  A. Noszczyk-Nowak,et al.  Short-term heart rate variability (HRV) in healthy dogs. , 2015, Polish journal of veterinary sciences.

[8]  J. Quimby,et al.  Evaluation of the effects of hospital visit stress on physiologic variables in dogs. , 2015, Journal of the American Veterinary Medical Association.

[9]  K. Liang,et al.  Heart rate variability parameters and ventricular arrhythmia correlate with pulmonary arterial pressure in adult patients with idiopathic pulmonary arterial hypertension. , 2014, Heart & lung : the journal of critical care.

[10]  Y. Hori,et al.  Effect of the phosphodiesterase type 5 inhibitor tadalafil on pulmonary hemodynamics in a canine model of pulmonary hypertension. , 2014, Veterinary journal.

[11]  M. Humbert,et al.  Pulmonary arterial hypertension , 2013, Orphanet Journal of Rare Diseases.

[12]  Makiko Uchida,et al.  Diagnostic utility of NT-proBNP and ANP in a canine model of chronic embolic pulmonary hypertension. , 2012, Veterinary journal.

[13]  R. Kloner,et al.  Cardiac uses of phosphodiesterase-5 inhibitors. , 2012, Journal of the American College of Cardiology.

[14]  M. Sleeper,et al.  Clinical efficacy of sildenafil in treatment of pulmonary arterial hypertension in dogs. , 2010, Journal of veterinary internal medicine.

[15]  H. Kellihan,et al.  Pulmonary hypertension in dogs: diagnosis and therapy. , 2010, The Veterinary clinics of North America. Small animal practice.

[16]  R. Naeije,et al.  Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension. , 2010, American journal of respiratory and critical care medicine.

[17]  M. Dörr,et al.  Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension , 2009, European Respiratory Journal.

[18]  R. Stepien,et al.  Sildenafil Citrate Therapy in 22 Dogs with Pulmonary Hypertension , 2007 .

[19]  S. Arai,et al.  A case of long-term sildenafil therapy in a young dog with pulmonary hypertension. , 2007, The Journal of veterinary medical science.

[20]  V. Eder,et al.  Heart rate variability in rats with chronic hypoxic pulmonary hypertension. , 2006, Annales de cardiologie et d'angeiologie.

[21]  M. Mcgoon,et al.  Pulmonary Arterial Hypertension , 2006, Circulation.

[22]  J. Loscalzo,et al.  Pulmonary arterial hypertension. , 2004, Annals of medicine.

[23]  A. Malliani,et al.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use , 1996 .

[24]  G. Breithardt,et al.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 1996 .

[25]  G. Nickenig,et al.  Heart Rate Variability and Arrhythmic Burden in Pulmonary Hypertension. , 2016, Advances in Experimental Medicine and Biology.

[26]  R. Stepien,et al.  Sildenafil citrate therapy in 22 dogs with pulmonary hypertension. , 2007, Journal of veterinary internal medicine.

[27]  J. Abbott,et al.  Pulmonary Hypertension and Cardiovascular Sequelae in 54 Dogs , 2004 .

[28]  T. Mitsui,et al.  Spectral analysis of circadian rhythms in heart rate variability of dogs. , 2001, American journal of veterinary research.

[29]  B. Sayers,et al.  Analysis of heart rate variability. , 1973, Ergonomics.